 |
|
|
| |
Sugen Life Sciences (SLS) has
optimized multiple platforms of pharmacological assays to address the important requirements of drug candidate development.
We provide a variety of preclinical in vivo efficacy models in different disease areas, including oncology, arthritis, diabetes and wound healing. We also offer pharmacokinetic and histology services to support these studies.
SLS offers following range of pharmacology efficacy models |
| |
 |
Diabetes |
|
Cancer |
|
Tissue repair and wound healing |
|
Osteoporosis |
|
Inflammation |
|
| |
| |
| |
| |
|
